EMAIL THIS PAGE TO A FRIEND

A4233 Sigma

Ara-G hydrate

≥98% (HPLC), solid

Synonym: 9-β-D-Arabinofuranosyl guanine hydrate

Purchase

Properties

Related Categories AN-AZ, Apoptosis Inducers, Apoptosis and Cell Cycle, Bioactive Small Molecule Alphabetical Index, Bioactive Small Molecules,
assay   ≥98% (HPLC)
form   solid
solubility   DMSO: >10 mg/mL
  H2O: insoluble
storage temp.   2-8°C

Description

Application

Ara-G is converted by cellular kinases to the active 5′-triphosphate, Ara-GTP. This active form of Ara-G induces apoptosis and inhibits DNA synthesis. Ara-G is also an antineoplastic and antimetabolite.

Biochem/physiol Actions

Ara-G is an inducer of apoptosis; inhibitor of DNA synthesis; antineoplastic; and antimetabolite. Ara-G is converted by cellular kinases to the active 5′-triphosphate, Ara-GTP. Incorporation of Ara-GTP into DNA leads to inhibition of DNA synthesis and apoptosis.

Features and Benefits

This compound is also offered as part of Sigma′s Library of Pharmacologically Active Compounds (LOPAC®,1280), a biologically annotated collection of high-quality, ready-to-screen compounds. Click here to learn more.

Legal Information

LOPAC is a registered trademark of Sigma-Aldrich Co. LLC

Price and Availability


DISCOVER Bioactive Small Molecules

Customers Also Viewed

2OHOA
SML02562OHOA

≥98% (HPLC)

SML0641BAM7

≥98% (HPLC)

CIL-102
C5492CIL-102

≥95% (HPLC), solid

Safety & Documentation

Safety Information

Symbol 
GHS07  GHS07
Signal word 
Warning
Hazard statements 
Precautionary statements 
Personal Protective Equipment 
WGK Germany 
3
RTECS 
MF8301000

Documents

Certificate of Analysis

Protocols & Articles

Peer-Reviewed Papers

References

Set your institution to view full text papers.

Nelarabine. Sanford, M., and Lyseng-Williamson, K.A. Drugs 68, 439-447, (2008)

Loading...


Nelarabine: a novel purine antimetabolite antineoplastic agent. Luie, L.W., et al. Clin. Ther. 29, 1887-1899, (2007)

Loading...


Purine nucleoside analogs as immunosuppressive and antineoplastic agents: mechanism of action and clinical activity. Robak, T., et al. Curr. Med. Chem. 13, 3165-3189, (2006)

Loading...


Nucleoside analogues: mechanisms of drug resistance and reversal stragegies. . Galmarini, C. M. , et al. Leukemia 15, 875, (2001)

Loading...


Enhanced toxicity of purine nucleoside analogs in cells expressing Drosophila melanogaster nucleoside kinase mutants. Solaroli N, Johansson M, Balzarini J, et al. Gene Ther. 14(1), 86-92, (2007)

Loading...


In vitro efficacy of forodesine and nelarabine (ara-G) in pediatric leukemia. Homminga I, Zwaan CM, Manz CY, et al. Blood 118(8), 2184-90, (2011)

Loading...


Nelarabine: a new purine analog in the treatment of hematologic malignancies. Curbo S and Karlsson A Rev. Recent Clin. Trials 1(3), 185-92, (2006)

Loading...


Differential incorporation of 1-beta-D-arabinofuranosylcytosine and 9-beta-D-arabinofuranosylguanine into nuclear and mitochondrial DNA. Zhu C, Johansson M, and Karlsson A FEBS Lett. 474(2-3), 129-32, (2000)

Loading...


Novel selective human mitochondrial kinase inhibitors: design, synthesis and enzymatic activity. Nunzia Ciliberti et al Bioorg. Med. Chem. 15, 3065-81, (2007)

Loading...


Arabinosylguanine is phosphorylated by both cytoplasmic deoxycytidine kinase and mitochondrial deoxyguanosine kinase. Rodriguez CO, Mitchell BS, Ayres M, et al. Cancer Res. 62(11), 3100-5, (2002)

Loading...


Low level of mitochondrial deoxyguanosine kinase is the dominant factor in acquired resistance to 9-beta-D-arabinofuranosylguanine cytotoxicity. Lotfi K, Månsson E, Peterson C, et al. Biochem. Biophys. Res. Commun. 293(5), 1489-96, (2002)

Loading...


Acute cytotoxicity of arabinofuranosyl nucleoside analogs is not dependent on mitochondrial DNA. Curbo S, Johansson M, Balzarini J, et al. Exp. Cell Res. 315, 2539-2543, (2009)

Loading...


Mechanisms for T-cell selective cytotoxicity of arabinosylguanine. Rodriguez CO, Stellrecht CM, and Gandhi V Blood 102(5), 1842-8, (2003)

Loading...


Pharmacokinetics of nelarabine and 9-beta-D-arabinofuranosyl guanine in pediatric and adult patients during a phase I study of nelarabine for the treatment of refractory hematologic malignancies. Kisor DF, Plunkett W, Kurtzberg J, et al. J. Clin. Oncol. 18(5), 995-1003, (2000)

Loading...


Dual mechanisms of 9-beta-D-arabinofuranosylguanine resistance in CEM T-lymphoblast leukemia cells. Curbo S, Zhu C, Johansson M, et al. Biochem. Biophys. Res. Commun. 285(1), 40-5, (2001)

Loading...


Effects of 9-beta-D-arabinofuranosylguanine on mitochondria in CEM T-lymphoblast leukemia cells. Curbo S, Zhivotovsky B, Johansson M, et al. Biochem. Biophys. Res. Commun. 307(4), 942-7, (2003)

Loading...


Resistance to mitochondrial- and Fas-mediated apoptosis in human leukemic cells with acquired resistance to 9-beta-D-arabinofuranosylguanosine. Månsson E, Stridh H, and Albertioni F Biochem. Biophys. Res. Commun. 298(3), 338-44, (2002)

Loading...


Synthesis of 2'-deoxy-2'-[18F]fluoro-9-β-D-arabinofuranosylguanine: a novel agent for imaging T-cell activation with PET. Namavari M, Chang YF, Kusler B, et al. Mol. Imaging Biol. 13(5), 812-8, (2011)

Loading...


Reduced levels of mitochondrial DNA increases the toxicity of 9-beta-D-arabinofuranosylguanine (araG). Bjerke M, Balzarini J, and Karlsson A Nucleosides Nucleotides Nucleic Acids 27(6), 746-9, (2008)

Loading...


Induction of fetal hemoglobin and ABCB1 gene expression in 9-β-D-arabinofuranosylguanine-resistant MOLT-4 cells. Fyrberg A, Peterson C, Kågedal B, et al. Cancer Chemother. Pharmacol. 68(3), 583-91, (2011)

Loading...


The novel nucleoside transport system exhibited by NB4 cells, csg, transports deoxyguanosine analogues, including ara-G. Flanagan SA, Gandhi V, Secrist JA, et al. Biochem. Pharmacol. 66(5), 733-7, (2003)

Loading...


Activation of guanine-β-D-arabinofuranoside and deoxyguanosine to triphosphates by a common pathway blocks T lymphoblasts at different checkpoints. Leanza L, Miazzi C, Ferraro P, et al. Exp. Cell Res. 316(20), 3443-53, (2010)

Loading...


Combination of guanine arabinoside and Bcl-2 inhibitor YC137 overcomes the cytarabine resistance in HL-60 leukemia cell line. Nishi R, Yamauchi T, Negoro E, et al. Cancer Sci. 104(4), 502-7, (2013)

Loading...


Plasma and cerebrospinal fluid pharmacokinetics of nelarabine in nonhuman primates. Berg SL, Brueckner C, Nuchtern JG, et al. Cancer Chemother. Pharmacol. 59(6), 743-7, (2007)

Loading...


Synthesis of 9-beta-d-arabinofuranosylguanine by combined use of two whole cell biocatalysts. Médici R, Iribarren AM, and Lewkowicz ES Bioorg. Med. Chem. Lett. 19(15), 4210-2, (2009)

Loading...


In vitro chemo-sensitivity of B-chronic lymphocytic leukaemia to ara-G. Bromidge T, Frewin R, and Johnson S Leuk. Res. 24(7), 623-6, (2000)

Loading...


A potential role of fetal hemoglobin in the development of multidrug resistance. Fyrberg A, Skoglund K, Wolk M, et al. Biochem. Biophys. Res. Commun. 427(3), 456-60, (2012)

Loading...


A new high-performance liquid chromatography method determines low production of 9-beta-D-arabinofuranosylguanine triphosphate, an active metabolite of nelarabine, in adult T-cell leukemia cells. Yamauchi T, Nishi R, Kitazumi K, et al. Oncol. Rep. 23(2), 499-504, (2010)

Loading...


Related Products

Technical Service:

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Bulk Ordering & Pricing:

Need larger quantities for your development, manufacturing or research applications?